Cross NC - Search Results

1

JAK2V617F allele burden is reduced by busulfan therapy: a new observation using an old drug.

Kuriakose ET, Gjoni S, Wang YL, Baumann R, Jones AV, Cross NC, Silver RT. Kuriakose ET, et al. Among authors: cross nc. Haematologica. 2013 Nov;98(11):e135-7. doi: 10.3324/haematol.2013.087742. Haematologica. 2013. PMID: 24186314 Free PMC article. No abstract available.

2

JAK2(V617F) allele burden in polycythemia vera correlates with grade of myelofibrosis, but is not substantially affected by therapy.

Silver RT, Vandris K, Wang YL, Adriano F, Jones AV, Christos PJ, Cross NC. Silver RT, et al. Among authors: cross nc. Leuk Res. 2011 Feb;35(2):177-82. doi: 10.1016/j.leukres.2010.06.017. Epub 2010 Jul 22. Leuk Res. 2011. PMID: 20650526 Free PMC article.

3

Decrease in JAK2 V617F allele burden is not a prerequisite to clinical response in patients with polycythemia vera.

Kuriakose E, Vandris K, Wang YL, Chow W, Jones AV, Christos P, Cross NC, Silver RT. Kuriakose E, et al. Among authors: cross nc. Haematologica. 2012 Apr;97(4):538-42. doi: 10.3324/haematol.2011.053348. Epub 2011 Nov 18. Haematologica. 2012. PMID: 22102708 Free PMC article.

4

Evaluation of serum erythropoietin values as defined by 2016 World Health Organization criteria for the diagnosis of polycythemia vera.

Silver RT, Krichevsky S, Gjoni S, Cross NCP. Silver RT, et al. Leuk Lymphoma. 2017 Nov;58(11):2768-2769. doi: 10.1080/10428194.2017.1300892. Epub 2017 Mar 20. Leuk Lymphoma. 2017. PMID: 28317411 No abstract available.

5

Amplification refractory mutation system, a highly sensitive and simple polymerase chain reaction assay, for the detection of JAK2 V617F mutation in chronic myeloproliferative disorders.

Chen Q, Lu P, Jones AV, Cross NC, Silver RT, Wang YL. Chen Q, et al. Among authors: cross nc. J Mol Diagn. 2007 Apr;9(2):272-6. doi: 10.2353/jmoldx.2007.060133. J Mol Diagn. 2007. PMID: 17384221 Free PMC article.

6

Evaluation of JAK2 in B and T cell neoplasms: identification of JAK2(V617F) mutation of undetermined significance (JMUS) in the bone marrow of three individuals.

Wang YL, Lee JW, Kui JS, Chadburn A, Cross NC, Knowles DM, Coleman M. Wang YL, et al. Among authors: cross nc. Acta Haematol. 2007;118(4):209-14. doi: 10.1159/000111532. Epub 2007 Nov 21. Acta Haematol. 2007. PMID: 18032883

7

No association between myeloproliferative neoplasms and the Crohn's disease-associated STAT3 predisposition SNP rs744166.

Jones AV, Cross NC. Jones AV, et al. Among authors: cross nc. Haematologica. 2010 Jul;95(7):1226-7. doi: 10.3324/haematol.2010.023390. Haematologica. 2010. PMID: 20595103 Free PMC article. No abstract available.

8

A Novel t(1;9)(p36;p24.1) JAK2 Translocation and Review of the Literature.

Levavi H, Tripodi J, Marcellino B, Mascarenhas J, Jones AV, Cross NCP, Gruenstein D, Najfeld V. Levavi H, et al. Acta Haematol. 2019;142(2):105-112. doi: 10.1159/000498945. Epub 2019 May 7. Acta Haematol. 2019. PMID: 31063994 Review.

9

Rapid identification of JAK2 exon 12 mutations using high resolution melting analysis.

Jones AV, Cross NC, White HE, Green AR, Scott LM. Jones AV, et al. Among authors: cross nc. Haematologica. 2008 Oct;93(10):1560-4. doi: 10.3324/haematol.12883. Epub 2008 Aug 12. Haematologica. 2008. PMID: 18698085 Free article.

10

Chronic neutrophilic leukemia with an associated V617F JAK2 tyrosine kinase mutation.

Mc Lornan DP, Percy MJ, Jones AV, Cross NC, Mc Mullin MF. Mc Lornan DP, et al. Among authors: cross nc. Haematologica. 2005 Dec;90(12):1696-7. Haematologica. 2005. PMID: 16330446

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

413 results

Search Page

Filters